J. B. Chemicals & Pharmaceuticals Limited (BOM:506943)
India · Delayed Price · Currency is INR 2,420.90
+30.20 (1.26%)
At close: Jul 7, 2026
BOM:506943 Market Cap
BOM:506943 has a market cap or net worth of 388.7 billion as of July 7, 2026. Its market cap has increased by 43.75% in one year.
Market Cap
388.70B
Enterprise Value
376.52B
Revenue
41.48B
Ranking
n/a
PE Ratio
54.46
Stock Price
2,420.90
Market Cap Chart
Since December 11, 2001, BOM:506943's market cap has increased from 408.70M to 388.70B, an increase of 95,005.27%. That is a compound annual growth rate of 32.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 388.70B | 36.30% |
| Dec 31, 2025 | 285.18B | -0.62% |
| Dec 31, 2024 | 286.94B | 13.93% |
| Dec 29, 2023 | 251.85B | 67.53% |
| Dec 30, 2022 | 150.33B | 9.43% |
| Dec 31, 2021 | 137.38B | 74.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dr. Reddy's Laboratories | 1.14T |
| Lupin | 1.14T |
| Abbott India | 570.58B |
| GlaxoSmithKline Pharmaceuticals | 406.68B |
| Rubicon Research | 224.42B |
| Granules India | 211.72B |
| AstraZeneca Pharma India | 205.56B |
| Caplin Point Laboratories | 199.54B |